dupe deal - Gilead, Royalty Pharma pay Emory for Emtriva royalties
Gilead Sciences and Royalty Pharma have purchased from Emory University the royalty interest associated with worldwide net sales of Emtriva (emtricitabine) for $341.25mm (65%) and $183.75mm (35%), respectively.
- Specialty Pharmaceuticals
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com